id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-E-0226-0011,FDA,FDA-2007-E-0226,Letter from U.S. Patent and Trademark Office to Jones Day,Other,Letter(s),2014-04-02T04:00:00Z,2014,4,2014-04-02T04:00:00Z,,2014-04-02T12:56:37Z,,0,0,090000648169763c
FDA-2007-E-0226-0010,FDA,FDA-2007-E-0226,U.S. Patent and Trademark Office to JONES DAY - Letter,Other,Letter(s),2013-11-04T05:00:00Z,2013,11,2013-11-04T05:00:00Z,,2013-11-04T20:19:27Z,,0,0,090000648146f8c0
FDA-2007-E-0226-0009,FDA,FDA-2007-E-0226,U.S. Patent and Trademark Office to JONES DAY - Letter,Other,Letter(s),2013-04-29T04:00:00Z,2013,4,2013-04-29T04:00:00Z,,2013-04-29T12:13:46Z,,0,0,09000064812aa96d
FDA-2007-E-0226-0008,FDA,FDA-2007-E-0226,FDA\CDER to United States Patent and Trademark Office - Letter,Other,Letter(s),2012-04-24T04:00:00Z,2012,4,2012-04-24T04:00:00Z,,2012-04-24T12:23:48Z,,0,0,0900006480ff6b08
FDA-2007-E-0226-0007,FDA,FDA-2007-E-0226,U.S. Patent and Trademark Office to FDA/CDER - Letter,Other,Letter(s),2012-04-03T04:00:00Z,2012,4,2012-04-03T04:00:00Z,,2012-04-03T16:28:21Z,,0,0,0900006480fe7a60
FDA-2007-E-0226-0006,FDA,FDA-2007-E-0226,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2012-03-15T04:00:00Z,2012,3,2012-03-15T04:00:00Z,,2024-03-15T10:53:46Z,,0,0,0900006480fd8053
FDA-2007-E-0226-0005,FDA,FDA-2007-E-0226,Determination of Regulatory Review Period for Purposes of Patent Extension: Brovana,Notice,General Notice,2011-06-23T04:00:00Z,2011,6,2011-06-23T04:00:00Z,2011-08-23T03:59:59Z,2025-12-15T21:00:45Z,2011-15691,0,0,0900006480e9c0d9
FDA-2007-E-0226-0004,FDA,FDA-2007-E-0226,FDA/CDER to United States Patent and Trademark Office - Letter,Other,LET-Letter,2011-05-31T04:00:00Z,2011,5,2011-05-31T04:00:00Z,,2011-05-31T17:18:05Z,,0,0,0900006480e34fa0
FDA-2007-E-0226-0003,FDA,FDA-2007-E-0226,USPTO to FDA/CDER,Other,LET-Letter,2010-12-21T05:00:00Z,2010,12,,,2010-12-27T18:52:44Z,,0,0,0900006480bbad42
FDA-2007-E-0226-0002,FDA,FDA-2007-E-0226,Patent Term Extension Application from Sepracor Inc.,Other,APP-Application,2008-12-05T05:00:00Z,2008,12,2008-12-05T05:00:00Z,,2025-12-12T20:05:40Z,,0,0,090000648042ae4a
FDA-2007-E-0226-0001,FDA,FDA-2007-E-0226,Letter from U.S. Patent and Trademark Office to FDA,Other,LET-Letter,2007-04-06T04:00:00Z,2007,4,,,2025-12-15T20:21:18Z,,0,0,090000648042ae49